IDiyas

For the Inventor, By the Inventor

Kawagoe, Japan

Shingo Yano

USPTO Granted Patents = 9

Average Co-Inventor Count = 5.0

ph-index = 7

Forward Citations = 233(Granted Patents)


Location History:

  • Hannou, JP (1995 - 1996)
  • Kawagoe, JP (1996 - 2004)

Company Filing History:

goldMedal9 out of 318 
 
Taiho Pharmaceutical Company Limited
 patents

Years Active: 1995-2004

Loading Chart...
9 patents (USPTO):
1. 6717002 - Method of producing steroid derivatives (2004-04-06),
2. 6294535 - Uracil derivatives and antitumor effect potentiator and antitumor agent containing the same (2001-09-25),
3. 6159969 - Uracil derivatives, and antitumor effect potentiator and antitumor agent (2000-12-12),
4. 5990139 - Thiazolidinedione derivatives or salts thereof and pharmaceutical (1999-11-23),
5. 5744475 - Uracil derivatives, and antitumor effect potentiator and antitumor agent (1998-04-28),
6. 5521202 - Thiazolidine derivatives and pharmaceutical compositions containing the (1996-05-28),
7. 5480899 - Oxazolidine derivatives and pharmaceutically acceptable salts thereof (1996-01-02),
8. 5475118 - 1-phenylpyrrolidone derivatives having optical activity, intermediate (1995-12-12),
9. 5401739 - Benzothiadiazine derivatives (1995-03-28),

Title: Shingo Yano: Innovator in Pharmaceutical Chemistry

Introduction

Shingo Yano is a prominent inventor based in Kawagoe, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds with potential therapeutic applications. With a total of 9 patents to his name, Yano's work has garnered attention in the scientific community.

Latest Patents

One of Yano's latest patents is focused on a method of producing steroid derivatives, specifically uracil derivatives that act as antitumor effect potentiators. This invention relates to novel uracil derivatives that exhibit excellent inhibiting effects on human-derived thymidine phosphorylase and demonstrate anti-tumor activity. The patent describes pharmaceutical compositions, anti-tumor potentiators, and antitumor agents containing these novel compounds, along with a process for their preparation and use.

Career Highlights

Yano is currently associated with Taiho Pharmaceutical Company Limited, where he continues to innovate and contribute to the development of new pharmaceutical solutions. His work is characterized by a commitment to advancing medical science and improving patient outcomes through innovative drug development.

Collaborations

Yano has collaborated with notable colleagues in his field, including Masakazu Fukushima and Kazuo Ogawa. These collaborations have further enriched his research and development efforts, leading to impactful advancements in pharmaceutical chemistry.

Conclusion

Shingo Yano's contributions to the field of pharmaceutical chemistry, particularly through his innovative patents, highlight his role as a key inventor in the industry. His work continues to pave the way for new therapeutic options in the fight against cancer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…